CAPR - Capricor Therapeutics Inc. (CAPR) CEO Linda Marbán on Q2 2021 Results - Earnings Call Transcript
Capricor Therapeutics, Inc. (CAPR) Q2 2021 Earnings Conference Call August 12, 2021 16:30 ET Company Participants AJ Bergmann - Chief Financial Officer Linda Marbán - Chief Executive Officer Conference Call Participants Emanuela Branchetti - H.C. Wainwright Alan Leong - BioWatch News Presentation Operator Ladies and gentlemen, good day and welcome to the Capricor Therapeutics Inc. Second Quarter 2021 Earnings Call. Today’s conference is being recorded. At this time, I would like to turn the conference over to AJ Bergmann for the forward-looking statement. Please go ahead, sir. AJ Bergmann Thank you. Before we start, I would like to state that we will be making certain forward-looking statements during today’s presentation. These statements may include statements regarding, among other things, the efficacy, safety and intended utilization of our product candidates, our future research and development plans, including our anticipated conduct and timing of preclinical and clinical studies, our plans to present
For further details see:
Capricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q2 2021 Results - Earnings Call Transcript